Navigation Links
PTC Therapeutics and Genzyme Announce Restructuring of Collaboration
Date:9/2/2011

oration therapy designed to enable the formation of a functioning protein in patients with genetic disorders caused by a nonsense mutation. A nonsense mutation is an alteration in the genetic code that prematurely halts the synthesis of an essential protein. The resulting disorder is determined by which protein cannot be expressed in its entirety and is no longer functional, such as dystrophin in nmDBMD. The development of ataluren has been supported by grants from Cystic Fibrosis Foundation Therapeutics Inc. (the nonprofit affiliate of the Cystic Fibrosis Foundation); Muscular Dystrophy Association; FDA's Office of Orphan Products Development; National Center for Research Resources; National Heart, Lung, and Blood Institute; and Parent Project Muscular Dystrophy.

ABOUT PTC THERAPEUTICS, INC.
PTC is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare genetic disorders, oncology and infectious diseases. PTC has developed proprietary technologies that it applies in its drug discovery activities and has served as the basis for collaborations with leading biopharmaceutical companies. For more information, visit the company's web site at www.ptcbio.com.

ABOUT GENZYME, A SANOFI COMPANY
One of the world's leading biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Since its founding in 1981, the company has introduced breakthrough treatments that have provided new hope for patients. The company's areas of focus are rare genetic diseases, multiple sclerosis, cardi
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
2. Repair Stem Cell Institute Announces Industrys First Standards of Excellence for Global Stem Cell Treatment Centers to Protect Patients from Less-than-Competent Therapeutics
3. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
4. BN ImmunoTherapeutics Announces Partnership With National Cancer Institute
5. Arno Therapeutics Announces Appointment of Brian Lenz, CPA as Chief Financial Officer
6. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
7. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
8. Nile Therapeutics, Inc. Reports 2008 Second Quarter Financial Results
9. Cell Therapeutics, Inc.s Second Quarter 2008 Financial Results
10. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
11. Arno Therapeutics Announces Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Ga. , Aug. 26, 2014  ViveBio, ... biological sample collection, stabilization and transportation, announced today ... Laboratory Procurement Services, LLC (LPS) of ... of products in the United States ... new class of ambient temperature dried biological specimen ...
(Date:8/26/2014)... The global market for molecular diagnostics ... according to a new study by Grand View Research, ... the subsequent introduction of advanced cancer diagnostic technologies are ... the next six years. Moreover, the growing global base ... coupled with disease triggering lifestyle habits such as smoking ...
(Date:8/26/2014)... WASHINGTON , Aug. 26, 2014 ... Next Generation Dx Summit; Moving Assays to ... "Targeted Detection and Monitoring of Cell Free Tumor ... the analytical component of its Precision Cancer Monitoring ... high clinical sensitivity for the detection of tumor ...
(Date:8/26/2014)... 2014  That,s Nice LLC, a research-focused strategic marketing ... formation of a new dedicated team that will support ... will combine current and new staff in both market ... Guy Tiene has been hired ... Tiene was previously Director of Marketing for Royal DSM,s ...
Breaking Biology Technology:ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 2World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 3World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 4World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 5World Molecular Diagnostics Market Is Expected To Grow To $8,020.1 Million From 2014 To 2020: Grand View Research, Inc 6Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 2Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 3Highly Sensitive and Quantitative Analytical Performance is Translational for Clinical Utility of Cell-Free Tumor DNA Diagnostics 4That's Nice Announces Expanded Offering For Strategic Content And Public Relations 2That's Nice Announces Expanded Offering For Strategic Content And Public Relations 3
... Pharmaceuticals Inc. (Nasdaq: VNDA ), a biopharmaceutical ... product candidates for central nervous system disorders, today announced ... December 31, 2008. Vanda reported a net loss ... compared to $10.9 million for the third quarter of ...
... Development Conference features presentations from industry and academic speakers who ... and chemical industries. Topics include Chemical and Process R&D, ... by Design (QbD). , ... Columbia, ...
... New Mexico, February 10, 2009A team of Los Alamos ... multiplicationwhen a photon creates multiple electronsis a real phenomenon ... born of extraneous effects that mimic carrier multiplication. The ... of Chemical Research , shows the possibility of solar ...
Cached Biology Technology:Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 2Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 3Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 4Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 5Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 6Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 7Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 8Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 9Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results 1016th International Process Development Conference to be Held June 14-17, 2009 in Arosa, Switzerland 2Research highlights potential for improved solar cells 2Research highlights potential for improved solar cells 3
(Date:8/26/2014)... New Zealand endemic tree has for the last 31 years ... Australian shrubs and small trees. A New Zealand botanist has ... astonishing cryptic diversity behind what was long considered a single ... journal PhytoKeys . , Known to botanists ... the many discoveries made in the north-western South Island of ...
(Date:8/26/2014)... assistant professor of mathematical sciences at New Jersey Institute ... into the biological clock that sets the pace for ... humans and all other mammals with fundamental rhythms of ... experienced each day and with seasonal change. The brain,s ... of sleep/wake behavior which, when disrupted by experiences such ...
(Date:8/26/2014)... social problems such as global warming and poverty ... the burden fall on our failure as consumers ... new study in the Journal of Consumer ... solving global problems from governments to consumers and ... businesses convince politicians to encourage responsible consumption instead ...
Breaking Biology News(10 mins):And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 2And then there were 10 -- unexpected diversity in New Zealand kanuka genus Kunzea 3Researching fundamental rhythms of life 2Researching fundamental rhythms of life 3An inconvenient truth: Does responsible consumption benefit corporations more than society? 2
... energy or one that,s environmentally destructive? That,s the question ... Society Forum session on fracking April 10, 2013 from 3 ... NJIT Technology and Society Forum is free and open to ... underground at high pressure to fracture rock formations in order ...
... yet available to build a comprehensive map of the activity ... world the human brain, scientists say in a newly ... and developed for the Brain Activity Mapping (BAM) Project, which ... Project did for genetics. Published in the journal ...
... prey, most of us picture stealthy lions and restless gazelle, ... But Ben Baiser, a post-doctoral fellow at the Harvard Forest ... , thinks on a more local scale. His inter-species drama ... North America, home to the carnivorous pitcher plant, Sarracenia ...
Cached Biology News:Fracking: Challenges and opportunities 2Brain Activity Mapping Project aims to understand the brain 2An inside look at carnivorous plants 2
NATIVE RAT OSTEOCALCIN...
Form: Ready to use Applications: ELISA...
Goat polyclonal to p27 KIP 1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: C-KRPATDDS STQNK, corresponding to Internal sequence amino acids 153-165 of Human p27 KIP 1 ...
Wnt-1 (G-19)...
Biology Products: